Please login to the form below

Not currently logged in


This page shows the latest clazakizumab news and features for those working in and with pharma, biotech and healthcare.

Sanofi's sarilumab beats Humira in head-to-head trial

Sanofi's sarilumab beats Humira in head-to-head trial

Other companies developing IL-6 inhibitors for RA include GlaxoSmithKline (GSK) and Janssen, whose sirukumab candidate is scheduled for filing later this year, and Alder Bio Pharmaceuticals which has clazakizumab in

Latest news

  • Positive data for BMS’ clazakizumab in arthritis Positive data for BMS’ clazakizumab in arthritis

    Bristol-Myers Squibb (BMS) could be adding another drug to its rheumatoid arthritis (RA) franchise after reporting encouraging phase IIb data on clazakizumab this week. ... Clazakizumab … provides promising remission data that will need to be further

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....